FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices 
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
NEW YORK, April 28, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Adeptus Health Inc. ("Adeptus Health Inc.") (NYSE:ADPT) between April 29, 2016 and March 1, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas, Tyler Division. To get more information go to:
http://www.zlk.com/pslra-sa/adeptus-health-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Adeptus had material weaknesses in its internal control over financial reporting in the areas of revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures; and (2) as a result, defendants’ statements about Adeptus’ business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in Adeptus Health Inc. you have until May 9, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
